Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies5
  • 7D5.0%
  • 3M12.6%
  • 1Y2.5%
  • YTD13.9%

Over the last 7 days, the Biotech industry has risen 5.0%, driven by gains from Zealand Pharma of 9.7%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024DKK 202.9bDKK 24.8bDKK 5.6b18.5x36x8.2x
Sun, 23 Jun 2024DKK 176.3bDKK 24.8bDKK 5.6b16.7x31.3x7.1x
Tue, 21 May 2024DKK 183.8bDKK 24.8bDKK 5.6b19.1x32.6x7.4x
Thu, 18 Apr 2024DKK 179.9bDKK 23.9bDKK 5.0b18.9x35.7x7.5x
Sat, 16 Mar 2024DKK 190.0bDKK 23.9bDKK 5.0b19.6x37.8x7.9x
Mon, 12 Feb 2024DKK 169.1bDKK 23.3bDKK 4.2b23x40.6x7.3x
Wed, 10 Jan 2024DKK 182.9bDKK 23.3bDKK 4.2b26.2x43.9x7.8x
Fri, 08 Dec 2023DKK 178.9bDKK 23.3bDKK 4.2b26x43x7.7x
Sun, 05 Nov 2023DKK 161.8bDKK 22.0bDKK 4.7b19.2x34.1x7.3x
Tue, 03 Oct 2023DKK 194.6bDKK 22.0bDKK 4.7b22.5x41.1x8.8x
Thu, 31 Aug 2023DKK 202.9bDKK 22.0bDKK 4.7b24x43x9.2x
Sat, 29 Jul 2023DKK 201.6bDKK 19.5bDKK 4.4b35.3x45.8x10.3x
Mon, 26 Jun 2023DKK 203.3bDKK 19.5bDKK 4.4b42.9x46.1x10.4x
Wed, 24 May 2023DKK 221.3bDKK 19.5bDKK 4.4b44.3x50.2x11.3x
Fri, 21 Apr 2023DKK 209.3bDKK 17.9bDKK 3.5b32.8x59.2x11.7x
Sun, 19 Mar 2023DKK 190.4bDKK 17.9bDKK 3.5b29.7x53.7x10.6x
Tue, 14 Feb 2023DKK 206.0bDKK 14.7bDKK 3.3b31.5x63x14x
Thu, 12 Jan 2023DKK 209.4bDKK 14.7bDKK 3.3b32x64x14.2x
Sat, 10 Dec 2022DKK 236.0bDKK 14.7bDKK 3.3b37.1x72.1x16x
Mon, 07 Nov 2022DKK 220.1bDKK 12.4bDKK 1.5b48.8x144.9x17.7x
Wed, 05 Oct 2022DKK 197.4bDKK 12.4bDKK 1.5b43.6x129.9x15.9x
Fri, 02 Sep 2022DKK 191.7bDKK 12.4bDKK 1.5b42.3x128.8x15.4x
Sun, 31 Jul 2022DKK 201.5bDKK 11.1bDKK 130.5m71.3x1544.2x18.2x
Tue, 28 Jun 2022DKK 169.4bDKK 11.1bDKK 130.5m62.6x1298.3x15.3x
Thu, 26 May 2022DKK 157.1bDKK 11.0b-DKK 88,588,000.0058.2x-1773.8x14.2x
Sat, 23 Apr 2022DKK 181.1bDKK 10.7bDKK 622.4m55.2x291x16.9x
Mon, 21 Mar 2022DKK 175.5bDKK 10.7bDKK 625.7m52.8x280.4x16.4x
Wed, 16 Feb 2022DKK 163.2bDKK 9.8bDKK 117.9m50.4x1383.4x16.6x
Fri, 14 Jan 2022DKK 173.2bDKK 9.8bDKK 117.9m52.1x1468.6x17.6x
Sun, 12 Dec 2021DKK 191.0bDKK 9.8bDKK 117.9m57.3x1619.8x19.4x
Tue, 09 Nov 2021DKK 226.4bDKK 9.3b-DKK 169,922,000.0078.3x-1332.6x24.3x
Thu, 07 Oct 2021DKK 210.7bDKK 9.3b-DKK 169,922,000.0072.5x-1239.9x22.6x
Sat, 04 Sep 2021DKK 233.9bDKK 9.3b-DKK 169,922,000.0079.7x-1376.2x25.1x
Mon, 02 Aug 2021DKK 213.0bDKK 9.3b-DKK 169,922,000.0074.1x-1253.3x22.9x
Price to Earnings Ratio

-1253.3x


Total Market Cap: DKK 213.0bTotal Earnings: -DKK 169,922,000.00Total Revenue: DKK 9.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 111.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 36.0x which is lower than its 3-year average PE of 111x.
  • The 3-year average PS ratio of 13.4x is higher than the industry's current PS ratio of 8.2x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 39% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market0.34%
Healthcare-0.20%
Biotech5.05%
Biotech5.05%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 932.509.7%
+DKK 5.8b
323.5%PS191.4x
GMAB GenmabDKK 1.93k4.1%
+DKK 4.8b
-28.4%PE22.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAVA

DKK 185.10

Bavarian Nordic

7D

-1.2%

1Y

30.2%

GMAB

DKK 1,926.50

Genmab

7D

4.1%

1Y

-28.4%

ZEAL

DKK 932.50

Zealand Pharma

7D

9.7%

1Y

323.5%

BIOPOR

DKK 2.22

BioPorto

7D

-0.7%

1Y

80.5%

ORPHA

DKK 820.10

Orphazyme

7D

-4.6%

1Y

-37.1%